Ohio State Navbar

Women's Behavioral Health

Review Articles


2013

Gur TL, Kim DR, Epperson CN. Central nervous system effects of prenatal selective serotonin reuptake inhibitors: sensing the signal through the noise. Psychopharmacology (Berl). 2013; 227(4):567-582.

 

2012

Padron K, Newport DJ.  I have a patient who has had recurrent depression whose condition is stable with an SSRI but wants to get pregnant.  Should she continue to take her antidepressant?  Ask the Expert – Women’s Mental Health.  Focus 2012; 10(1): 28-30.

 

2009

Diefenbach M, Turner G, Carpenter KM, Sheldon LK, Mustian KM, Gerend MA, Rini C, von Wagner C, Gritz ER, McQueen A, Prayor-Patterson HM, Miller SM.  Cancer and patient-physician communication.  J Health Commun 2009; 14 Suppl 1: 57-65.

Ancker JS, Carpenter KM, Greene P, Hoffman R, Kukafka R, Marlow LA, Prigerson HG, Quillin JM.  Peer-to-peer communication, cancer prevention, and the internet. J Health Commun 2009; 14 Suppl 1:38-46.

 

2007

Wang JS, Newport DJ, Stowe ZN, Donovan JL, Pennell PB, DeVane CL. The emerging importance of transporter proteins in the psychopharmacological treatment of the pregnant patient. Drug Metab Rev 2007; 39:723-746.

Stowe ZN, Newport DJ. The management of bipolar disorder during pregnancy. Medscape CME 2007.

 

2006

DeVane CL, Stowe ZN, Donovan JL, Newport DJ, Pennell PB, Ritchie JC, Owens MJ, Wang JS. Therapeutic drug monitoring of psychoactive drugs during pregnancy in the genomic era: challenges and opportunities. J Psychopharmacol 2006; 20:54-59.

King E, Stowe ZN, Newport DJ. Using antidepressants during pregnancy: an update. Psychiatr Times 2006; 23(9): 90-95.

 

2005

Carpenter KM, Andersen BL.  Reclassification will not make the pain go away. Peer commentary on Binik’s “Should dyspareunia be retained as a sexual dysfunction in DSM-V? A painful classification decision.  Arch Sex Behav 2005; 34(1): 26-8, 57-61.

 

2004

Henry AL, Beach AJ, Stowe ZN, Newport DJ. The fetus and maternal depression: implications for antenatal treatment guidelines. Clin Obstet Gynecol 2004; 47(3): 535-546.

Levey L, Ragan K, Hower-Hartley A, Newport DJ, Stowe ZN. Psychiatric disorders in pregnancy. Neurol Clin 2004; 22(4): 863-893.

 

2003

Newport DJ, Stowe ZN. Clinical management of perinatal depression: focus on paroxetine. Psychopharmacol Bull 2003; 37(Supplement 1): 148-166.

 

2002

Newport DJ, Wilcox MM, Stowe ZN. Maternal depression: a child's first adverse life event. Semin Clin Neuropsychiatry 2002; 7(2): 113-119.

Newport DJ, Stowe ZN, Nemeroff CB. Parental depression: animal models of an adverse life event. Am J Psychiatry 2002; 159(8): 1265-1283.

Newport DJ, Hostetter A, Arnold A, Stowe ZN. The treatment of postpartum depression: minimizing infant exposures. J Clin Psychiatry 2002; 63(Supplement 7): 31-44.

 

2001

Stowe ZN, Calhoun K, Ramsey C, Sadek N, Newport DJ. Mood disorders during pregnancy and lactation: defining issues of exposure and treatment. CNS Spectr 2001; 6(2): 150-166.

Newport DJ, Wilcox MM, Stowe ZN. Antidepressants during pregnancy and lactation: defining exposure and treatment issues. Semin Perinatol 2001; 25(3): 177-190.

 

1999

Stowe ZN, Newport DJ. Depression in women: recognition and treatment. Women’s Health in Primary Care 1999; 1(Supplement): 29-39.

Newport DJ. Mood and psychotic disorders in women: an update on treatment, part 2. Resident & Staff Physician 1999; (Special supplement): 24-26.